Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Tenet Healthcare



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole was unchanged today. By the end of trading, Tenet Healthcare rose $1.52 (3.5%) to $45.36 on heavy volume. Throughout the day, 3,107,298 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1,883,000 shares. The stock ranged in a price between $43.90-$45.37 after having opened the day at $44.22 as compared to the previous trading day's close of $43.84. Other companies within the Health Care sector that increased today were:

Transition Therapeutics



), up 37.8%,

Pain Therapeutics



), up 26.0%,

Durect Corporation



), up 25.6% and

Bacterin International Holdings



), up 18.1%.

  • EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.2 billion and is part of the health services industry. The company has a P/E ratio of 23.5, above the S&P 500 P/E ratio of 17.7. Shares are up 26.8% year to date as of the close of trading on Monday.

TheStreet Ratings rates Tenet Healthcare as a


. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins.

On the negative front,

Delcath Systems



), down 40.1%,

AVEO Pharmaceuticals



), down 31.3%,




), down 20.6% and




), down 16.8% , were all laggards within the health care sector with

Eli Lilly and Company



) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care




Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.